Arsanis, Inc. Business Finance Contracts & Agreements

68 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Second Amended and Restated Loan and Security Agreement, dated as of August 2, 2023, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules...
Loan Agreements
Arsanis, Inc.
Biotechnology
CA
2023
X4 Pharmaceuticals, Inc. Amended and Restated 2017 Employment Stock Purchase Plan
Stock Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Registration Rights Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Securities Purchase Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Form of May 2023 Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Form of Class C Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated December 7, 2022, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, and Cantor Fitzgerald & Co
Underwriting Agreements
Arsanis, Inc.
Biotechnology
NY
2022
Amendment No. 4 to Amended and Restated Loan and Security Agreement, dated as of June 30, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries...
Loan Agreements
Arsanis, Inc.
Biotechnology
2022
Registration Rights Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Form of Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Registration Rights Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Amendment No. 3 to Amended and Restated Loan and Security Agreement, dated as of February 9, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries...
Loan Agreements
Arsanis, Inc.
Biotechnology
2022
Registration Rights Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
IL
2022
Purchase Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Arsanis, Inc.
Biotechnology
IL
2022
Registration Rights Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Registration Rights Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Amendment No. 2 to Amended and Restated Loan and Security Agreement, dated as of December 21, 2020, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries...
Loan Agreements
Arsanis, Inc.
Biotechnology
2020
Common Stock Purchase Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC
Stock Agreements
Arsanis, Inc.
Biotechnology
IL
2020
Registration Rights Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
IL
2020
Resignation Agreement and Release by and between X4 Pharmaceuticals, Inc. and E. Lynne Kelley, M.D., dated March 18, 2020
Release Agreements
Arsanis, Inc.
Biotechnology
MA
2020
Amendment No. 1 to Loan and Security Agreement, dated March 13, 2020, by and between X4 Pharmaceuticals, Inc. and Hercules Capital, Inc
Loan Agreements
Arsanis, Inc.
Biotechnology
2020
Form of Class B Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Underwriting Agreement, dated November 26, 2019, by and among the Company, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Underwriting Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amended and Restated Loan and Security Agreement, dated as of June 27, 2019, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc. and Hercules...
Loan Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Warrant Agreement, dated as of March 18, 2019, by and between the Company and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Amended and Restated Warrant Agreement, dated as of March 29, 2019, by and between the Company and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Form of Class A Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Underwriting Agreement, dated April 12, 2019, by and among the Company, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Underwriting Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amendment No. 1 to Loan and Security Agreement, dated as of December 11, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc
Loan Agreements
Arsanis, Inc.
Biotechnology
2019
Loan and Security Agreement, dated as of October 19, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc
Loan Agreements
Arsanis, Inc.
Biotechnology
CA
2019